Rognoni, C., Bertolani, A. and Jommi, C. (2018) “Budget impact analysis of rituximab biosimilar in Italy from the hospital and payer perspectives”, Global and Regional Health Technology Assessment, 5(1). doi: 10.33393/grhta.2018.440.